Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

80 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary Outcome Evaluation of a Next-Generation Left Atrial Appendage Closure Device: Results From the PINNACLE FLX Trial.
Kar S, Doshi SK, Sadhu A, Horton R, Osorio J, Ellis C, Stone J Jr, Shah M, Dukkipati SR, Adler S, Nair DG, Kim J, Wazni O, Price MJ, Asch FM, Holmes DR Jr, Shipley RD, Gordon NT, Allocco DJ, Reddy VY; PINNACLE FLX Investigators. Kar S, et al. Among authors: nair dg. Circulation. 2021 May 4;143(18):1754-1762. doi: 10.1161/CIRCULATIONAHA.120.050117. Epub 2021 Apr 6. Circulation. 2021. PMID: 33820423 Free article.
Usefulness of Multisite Ventricular Pacing in Nonresponders to Cardiac Resynchronization Therapy.
Saba S, Nair D, Ellis CR, Ciuffo A, Cox M, Gupta N, Sharma S, Jain S, Winner M, Mehta S, Simon T, Stein K, Ellenbogen KA; Strategic Management to Improve CRT Using Multi-Site Pacing (SMART-MSP) Investigators. Saba S, et al. Am J Cardiol. 2022 Feb 1;164:86-92. doi: 10.1016/j.amjcard.2021.10.027. Epub 2021 Nov 20. Am J Cardiol. 2022. PMID: 34815062 Free article.
Contact force catheter ablation for the treatment of persistent atrial fibrillation: Results from the PERSIST-END study.
Lo M, Nair D, Mansour M, Calkins H, Reddy VY, Colley BJ 3rd, Tanaka-Esposito C, Sundaram S, DeLurgio DB, Sanders P, Khatib S, Bernard M, Olson N, Gibson D, Miller A, Li J, Natale A. Lo M, et al. J Cardiovasc Electrophysiol. 2023 Feb;34(2):279-290. doi: 10.1111/jce.15742. Epub 2022 Nov 20. J Cardiovasc Electrophysiol. 2023. PMID: 36352771
Two-Year Outcomes With a Next-Generation Left Atrial Appendage Device: Final Results of the PINNACLE FLX Trial.
Doshi SK, Kar S, Sadhu A, Horton R, Osorio J, Ellis C, Stone J Jr, Shah M, Dukkipati SR, Adler S, Nair DG, Kim J, Wazni O, Price MJ, Holmes DR Jr, Shipley R, Christen T, Allocco DJ, Reddy VY; PINNACLE FLX investigators [Link]. Doshi SK, et al. Among authors: nair dg. J Am Heart Assoc. 2023 Feb 21;12(4):e026295. doi: 10.1161/JAHA.122.026295. Epub 2023 Feb 15. J Am Heart Assoc. 2023. PMID: 36789852 Free PMC article.
A Dual-Chamber Leadless Pacemaker.
Knops RE, Reddy VY, Ip JE, Doshi R, Exner DV, Defaye P, Canby R, Bongiorni MG, Shoda M, Hindricks G, Neužil P, Rashtian M, Breeman KTN, Nevo JR, Ganz L, Hubbard C, Cantillon DJ; Aveir DR i2i Study Investigators. Knops RE, et al. N Engl J Med. 2023 Jun 22;388(25):2360-2370. doi: 10.1056/NEJMoa2300080. Epub 2023 May 20. N Engl J Med. 2023. PMID: 37212442
Rationale and design of a randomized study comparing the Watchman FLX device to DOACs in patients with atrial fibrillation.
Kar S, Doshi SK, Alkhouli M, Camm AJ, Coylewright M, Gibson MC, Granger CB, Gurol ME, Huber K, Mansour M, Nair DG, Natale A, Pocock SJ, Reddy VR, Saliba W, Christen T, Allocco DJ, Ellenbogen KA, Leon MB. Kar S, et al. Among authors: nair dg. Am Heart J. 2023 Oct;264:123-132. doi: 10.1016/j.ahj.2023.05.022. Epub 2023 Jun 4. Am Heart J. 2023. PMID: 37279840 Free article. Clinical Trial.
3-Year Outcomes From the Amplatzer Amulet Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE).
Lakkireddy D, Thaler D, Ellis CR, Swarup V, Gambhir A, Hermiller J, Nielsen-Kudsk JE, Worthley S, Nair D, Schmidt B, Horton R, Gupta N, Anderson JA, Gage R, Alkhouli M, Windecker S. Lakkireddy D, et al. JACC Cardiovasc Interv. 2023 Aug 14;16(15):1902-1913. doi: 10.1016/j.jcin.2023.06.022. JACC Cardiovasc Interv. 2023. PMID: 37587599 Clinical Trial.
80 results